School of Basic Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.
Department of Mental Health, Gansu Provincial Centre for Disease Control and Prevention, Lanzhou, Gansu, China.
PLoS One. 2023 Feb 21;18(2):e0281469. doi: 10.1371/journal.pone.0281469. eCollection 2023.
Hypertension, one of the most common chronic diseases worldwide, usually requires lifetime managing blood pressure (BP) with medications. Due to quite large number of hypertension patients co-exist with depression and/or anxiety, and non-cooperated with medical instruction, consequently management of BP is impaired with serious complications, resulting in compromised quality of life. Consequently quality of life of such patients is impaired with serious complications. Therefore, management of depression and/or anxiety is equally important as the treatment of hypertension. Depression and/or anxiety are independent risk factors of hypertension, which is supported by the finding that there is close correlation between hypertension are depression/or anxiety. Psychotherapy (non-drug treatment) maybe useful for hypertensive patients with depression and/or anxiety to improve their negative emotions. We aim to quantify the effective of psychological therapies in the management of hypertension patients with depression or anxiety, by comparing and ranking a network meta-analysis (NMA).
Literature search for randomized controlled trials (RCTs) will be performed in five electronic databases from inception to December 2021, including PubMed, the Cochrane library, Embase, Web of Science, and China Biology Medicine disc (CBM). The search terms mainly include "hypertension", "mindfulness-based stress reduction" (MBSR), "cognitive behavioral therapy" (CBT) and "dialectical behavior therapy" (DBT). Cochrane Collaboration quality assessment tool will be used for the risk of bias assessment. A Bayesian network meta-analysis will be performed, using WinBUGS 1.4.3, and Stata 14 will be applied to draw the network diagram, while RevMan 5.3.5 will be used to produce funnel plot for assessing the risk of publication bias. Recommended rating, development and grade methodology will also be utilized to assess the quality of evidence.
Effect of MBSR, CBT and DBT will be evaluated by traditional meta-analysis directly and Bayesian network meta-analysis indirectly. Our study will provide the evidence on the efficacy and safety of psychological treatments in the hypertension patients with anxiety. There is no research ethical requirement because this is a systematic review of published literature. The results of this study will be published in a peer-reviewed journal.
Prospero registration number: CRD42021248566.
高血压是全球最常见的慢性病之一,通常需要终生服用药物来控制血压(BP)。由于相当多的高血压患者同时患有抑郁和/或焦虑症,并且不配合医嘱,因此血压控制受到严重影响,并导致生活质量受损。因此,这些患者的生活质量受到严重影响。因此,治疗抑郁和/或焦虑与治疗高血压同样重要。抑郁和/或焦虑是高血压的独立危险因素,这一观点得到了高血压与抑郁/焦虑密切相关的研究结果的支持。心理治疗(非药物治疗)可能对伴有抑郁和/或焦虑的高血压患者有用,以改善他们的负面情绪。我们旨在通过比较和排序网络荟萃分析(NMA)来量化心理疗法在管理高血压伴抑郁或焦虑患者中的效果。
从 2021 年 1 月 1 日至 2021 年 12 月,我们将在五个电子数据库中进行随机对照试验(RCT)的文献检索,包括 PubMed、Cochrane 图书馆、Embase、Web of Science 和中国生物医学文献数据库(CBM)。搜索词主要包括“高血压”、“正念减压”(MBSR)、“认知行为疗法”(CBT)和“辩证行为疗法”(DBT)。Cochrane 协作组质量评估工具将用于评估偏倚风险。我们将使用 WinBUGS 1.4.3 进行贝叶斯网络荟萃分析,并使用 Stata 14 绘制网络图,同时使用 RevMan 5.3.5 生成漏斗图以评估发表偏倚的风险。推荐评级、制定和分级方法也将用于评估证据质量。
我们将直接通过传统荟萃分析和间接通过贝叶斯网络荟萃分析来评估 MBSR、CBT 和 DBT 的效果。我们的研究将提供关于焦虑症高血压患者心理治疗疗效和安全性的证据。由于这是对已发表文献的系统评价,因此没有研究伦理要求。本研究结果将发表在同行评议的期刊上。
Prospero 注册号:CRD42021248566。